Dividends Calendar Earnings Calendar
GOSS

GOSS | Gossamer Bio Inc

Gossamer Bio Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   California, United States

Trade prices

  • Volume:
  • Market Cap: 644.7M
  • Prev closed:
  • Open: 9.06
  • High: 9.72
  • Low: 8.82
  • 52 week low: 7.04
  • 52 week high: 14.3
  • Dividends:No Dividends

Next ER: November 15, 2022 



Top Stories (GOSS)

    Company Profile

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 24, 2023
    November 15, 2022- / -0.6672- / -
    November 3, 2022-0.65 / -0.6581- / -
    August 10, 2022- / -0.6998- / -
    May 17, 2022- / -0.7994- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 15, 2022 14.240 13.550
    14.270
    13.550
    859.80K 2.67%
    Aug 12, 2022 13.870 13.440
    13.960
    13.320
    973.70K 4.68%
    Aug 11, 2022 13.250 13.720
    13.760
    12.820
    2.69M -2.72%
    Aug 10, 2022 13.620 13.020
    13.940
    13.010
    2.08M 5.01%
    Aug 9, 2022 12.970 12.600
    13.000
    12.130
    1.44M -0.38%
    Aug 8, 2022 13.020 13.060
    13.470
    12.810
    1.22M 0.54%
    Aug 5, 2022 12.950 12.615
    13.050
    12.530
    1.38M 0.78%
    Aug 4, 2022 12.850 12.350
    12.990
    12.225
    1.22M 4.90%
    Aug 3, 2022 12.250 11.890
    12.330
    11.782
    1.56M 3.99%
    Aug 2, 2022 11.780 11.220
    11.810
    11.200
    760.15K 5.46%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2015
    • Employees:118

    News

    News for (GOSS)

    This company doesn't provide a dividend.

    Key Persons

    • Chairman :  Chairperson: Faheem Hasnain
    • CEO :  Sheila Gujrathi M.D.
    • CFO :  Bryan Giraudo

    Talk about Gossamer Bio Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 15, 2022 (Same day)

    vod goss crsr alvr cdlx vray dlo dq avdx 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis